
Twist Bioscience Corporation (NASDAQ:TWST) on Friday posted mixed fourth-quarter results, reporting a loss of 45 cents per share, slightly wider than the consensus estimate of a 43-cent loss.
Sales reached $99.01 million, up 17% year over year, beating the consensus of $97.32 million.